期刊文献+

[2,7,12,18-四甲基-3,8-二(1-羟基乙基)-13,17-二羧基乙基]-卟啉的改进合成 被引量:3

A Modified Synthesis of [2,7,12,18-Tetramethyl-3,8-bis(1-hydroxy ethyl)-13,17-dicarboxy ethyl]-porphyrin
下载PDF
导出
摘要 在酸性条件下,氯化血红素(Ⅰ)与还原性铁粉作用生成原卟啉(Ⅱ),通过HBr-冰醋酸加成不经提纯直接加入NaOH溶液,OH-取代仲位Br制得[2,7,12,18-四甲基-3,8-二(1-羟基乙基)-13,17-二羧基乙基]-卟啉(血卟啉,Ⅲ),反应总产率达到90.6%。探讨了脱铁过程中反应温度、时间、还原剂用量等因素对原卟啉(Ⅱ)合成的影响,反应时间和pH对血卟啉(Ⅲ)合成的影响。结果表明,当氯化血红素和铁粉的摩尔比为1∶1、反应温度为110℃时,原卟啉的产率最高达98.3%;当pH=10,反应时间为6 h时,血卟啉的产率最高达92.1%。通过IR、MS和1HNMR对产物结构进行了表征。 Protoporhyrin(Ⅱ) was prepared by the demetalation reaction of hemin using HCOOH-Fe powder.And the target product of[2,7,12,18-tetramethyl-3,8-bis(1-hydroxy ethyl)-13,17-dicarboxy ethyl]-porphyrin(hematoporphyrin) was prepared through the "one pot" reaction of an HBr-acetic acid addition reaction and an OH-nucleophilic substitution reaction from protoporphyrin without purifying the intermediate.The total yield of hematoporphyrin(Ⅲ) is 90.6%.The effects of temperature,time and the dosage of reducing agent to Ⅱ and the effect of pH and time on the yield of Ⅲ were investigated.The results show that the yield of Ⅱ reaches a maximum of 98.3% in the molar ratio of hemin to Fe powder 1∶ 1 and at the the temperature of 110 ℃ and the optimal reaction pH and reaction time are 10 and 6 h respectively with a maximum yield of 92.1% in the synthesis of product Ⅲ.The target products were characterized with FT-IR,ESI-MS and ^1HNMR.
出处 《精细化工》 EI CAS CSCD 北大核心 2011年第2期205-208,共4页 Fine Chemicals
基金 江苏省自然科学基金(BK2009386) 南京理工大学科技发展基金(2010GJPY043)~~
关键词 血红素 血卟啉 卟啉衍生物 hemin; hematoporphyrin; porphyrin derivatives
  • 相关文献

参考文献10

二级参考文献12

共引文献10

同被引文献30

  • 1田华,黄锁义,郝振文.卟啉类抗癌药物的研究进展[J].化学研究,2004,15(3):63-67. 被引量:6
  • 2黄齐茂,陈彰评,陈世清,徐汉生,周翔.新型2-氢醌-多羟基卟啉的合成及其抗菌活性研究[J].化学学报,2004,62(21):2182-2186. 被引量:12
  • 3贾志云,邓候富.血卟啉类化合物在肿瘤诊疗应用的研究进展[J].中国医药工业杂志,2006,37(6):426-430. 被引量:8
  • 4Hu Bing-cheng, Zhou Wei-you, Ma Deng-sheng,et al. Metallo- deuteroporphyrins as catalysts for the oxidation of cyclohexane with air in the absence of additives and solvents [ J ]. Catalysis Communcation ,2008,10:83 - 85. 被引量:1
  • 5Steven H,Sehnan M D. Photodynamic therapy for prostate cancer: one urologist's perspective [ J ]. Photodiagnosis and Photodynamic Therapy,2007,4:26 - 30. 被引量:1
  • 6Koren H, Ahh G. Photodynamic therapy in gynaecologic cancer [J]. Journal of Photochemistry and Photobiology B : Biology, 1996, 36:189 - 191. 被引量:1
  • 7Brunner H, Arndt M R, Treittinger B. Porphyrin platinum conjugates-new aims [ J ]. Inorganica Chimica Acta, 2004, 357 : 1649 - 1669. 被引量:1
  • 8Vincent S, Vincent C, Robert G, et al. An efficient route todimeric porphyrine-RGD peptide conjugates via olefln metathesis [ J]. Tetrahedron ,2008,64:364 - 371. 被引量:1
  • 9Sylvain I, Zerrouki R, Granet R, et al. Synthesis and biological evaluation of thioglycosylated porphyrins for an application in photodynamic therapy [ J ]. Bioorganic & Medicinal Chemistry, 2002,10:57 - 69. 被引量:1
  • 10Lepore S D, He Y. Use of sonication for the coupling of sterically hindered substrates in the phenolic Mitsunobu reaction[J]. J Org Chem ,2003,68:8261 - 8263. 被引量:1

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部